Reims, France

Bernard Christophe Barlaam

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 111(Granted Patents)


Location History:

  • Wilmington, DE (US) (2003 - 2004)
  • Reims, FR (2006 - 2013)
  • Reims, Cedex, FR (2013)
  • Cheshire, GB (2015 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Bernard Christophe Barlaam: A Pioneering Inventor in Cancer Treatment**

Introduction

Bernard Christophe Barlaam is a distinguished inventor based in Reims, France, renowned for his significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With an impressive portfolio of 18 patents, Barlaam's work embodies the essence of innovation and dedication to advancing medical research.

Latest Patents

Among his most recent patents is the development of Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer. This patent specification focuses on compounds described by a specific formula, including pharmaceutically acceptable salts. These compounds are designed to address ATM kinase-mediated diseases, including various forms of cancer. The specification outlines not only the therapeutic applications of these compounds but also discusses their crystalline forms, pharmaceutical compositions, and methods of manufacture, demonstrating a comprehensive approach to tackling cancer treatment.

Career Highlights

Barlaam's career at AstraZeneca AB has been marked by a dedication to innovation in drug development. His research has significantly contributed to the understanding and treatment of cancer, showcasing the importance of academic and practical knowledge in the pharmaceutical industry. His work continues to inspire numerous colleagues and aspiring inventors in the medical field.

Collaborations

Throughout his career, Bernard Christophe Barlaam has collaborated with esteemed professionals, including Richard Ducray and Nicholas John Newcombe. These collaborations have enriched his research and development efforts, leading to breakthroughs that are invaluable for cancer therapies.

Conclusion

Bernard Christophe Barlaam's contributions to the field of pharmaceuticals exemplify the impact of dedicated research and innovation on healthcare. With his notable patents and collaborative efforts, Barlaam continues to play a crucial role in the fight against cancer, inspiring future generations of inventors and researchers. His work not only highlights the importance of scientific inquiry but also emphasizes the potential for innovative solutions to address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…